Core Insights - Elastic Cloud Hosted has achieved FedRAMP® High authorization on AWS GovCloud (US), allowing U.S. federal agencies to utilize it for mission-critical applications involving sensitive government data [1][2] Group 1: Authorization and Security - The FedRAMP High authorization is the most stringent security baseline, requiring over 400 security controls to protect highly sensitive, unclassified government data [2] - This authorization enables federal agencies to deploy Elastic Cloud Hosted for high-impact workloads, including cyber defense, investigations, and AI-powered applications [2][3] Group 2: Federal Collaboration and Impact - Elastic's growing federal presence includes partnerships with the Cybersecurity and Infrastructure Security Agency (CISA) and the General Services Administration (GSA) to enhance procurement and operational efficiencies [5] - The FedRAMP High authorization supports agencies in law enforcement, emergency response, public health, financial systems, and national security operations [3][4] Group 3: Technological Capabilities - Elastic's architecture supports Kubernetes, OpenTelemetry, and other Cloud Native Computing Foundation projects, which help agencies avoid vendor lock-in and manage data retention costs [6] - Elastic Cloud Hosted also facilitates advanced search and GenAI use cases, allowing agencies to connect their data to large language models securely [8]

Core Viewpoint - ASM International N.V. is set to report its first quarter 2026 financial results on April 21, 2026, at 6:00 p.m. CET, followed by a conference call on April 22, 2026, at 3:00 p.m. CET [1] Group 1: Financial Reporting - The first quarter 2026 financial results will be reported on April 21, 2026, at approximately 6:00 p.m. CET [1] - A quarterly earnings conference call and webcast will take place on April 22, 2026, at 3:00 p.m. CET [1] - Participants are required to pre-register to receive dial-in numbers, passcode, and personal PIN for the conference call [1] Group 2: Company Overview - ASM International N.V. is headquartered in Almere, the Netherlands, and specializes in designing and manufacturing equipment and process solutions for semiconductor device production [3] - The company operates facilities in the United States, Europe, and Asia [3] - ASM's common stock is traded on the Euronext Amsterdam Stock Exchange under the symbol ASM [3]

Core Insights - Cyabra, Inc. has signed a yearly six-figure agreement with a major Fortune 500 consumer brand to provide real-time narrative intelligence and evidence-based protection [1][4] - The agreement highlights a growing recognition among organizations of the need for clear, evidence-based visibility to protect authenticity and respond to coordinated online manipulation [2][3] Company Overview - Cyabra specializes in helping enterprises and governments restore trust and authenticity in the face of manipulated content and inauthentic online behaviors [5] - The company's solution analyzes operational dynamics, amplifying activities, and narrative leverage, translating evidence into actionable mitigation steps [5] Industry Context - The rise of generative AI and sophisticated inauthentic activities has made online narrative integrity a core business risk, with a narrowed window between emerging threats and measurable impacts [3] - Organizations are increasingly aware that coordinated activities can distort perception and impact revenue within hours, necessitating rapid and evidence-backed responses [2][3]

Core Viewpoint - Eos Energy Enterprises, Inc. is facing a securities class action lawsuit due to allegations of misleading statements and failure to disclose critical operational issues during the class period from November 5, 2025, to February 26, 2026 [2]. Group 1: Allegations - The lawsuit claims that Eos Energy was unable to meet its production and capacity utilization targets as previously guided [2]. - It is alleged that the company's battery line downtime exceeded industry norms and internal forecasts [2]. - The company reportedly faced delays in achieving quality targets for its automated bipolar production [2]. - Eos Energy's systems and processes were deemed inadequate, leading to inaccurate public disclosures and guidance [2]. - As a result of these issues, the positive statements made by the company regarding its business and prospects were considered materially misleading [2]. Group 2: Class Action Details - Shareholders who purchased EOSE shares during the specified class period are encouraged to register for the class action, with a lead plaintiff appointment deadline set for May 5, 2026 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. - Participation in the class action incurs no cost or obligation for the shareholders [3].

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against Snowflake Inc. (NYSE: SNOW) for allegedly issuing materially false and misleading statements during the class period from June 27, 2023, to February 28, 2024, which may have led to investor losses [2][4]. Group 1: Allegations and Impact - The lawsuit claims that Snowflake's management failed to disclose that product efficiency gains, specifically related to Iceberg Tables and tiered storage pricing, were expected to negatively impact consumption and revenues [2]. - As a result of these undisclosed factors, the positive statements made by the defendants regarding consumption patterns, revenues, and demand for Snowflake products were deemed to lack a reasonable basis [2]. Group 2: Class Action Details - Shareholders who purchased shares of SNOW during the specified class period are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for April 27, 2026 [3]. - Participants in the class action will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle, with no cost or obligation to participate [3].

Core Perspective - P2 Solar, Inc. is establishing a new subsidiary, P2 CleanTech Labs, dedicated to carbon mitigation research and development, particularly focusing on genetically engineered bacteria for carbon capture applications [1][2]. Group 1: Company Initiatives - The formation of P2 CleanTech Labs is part of P2 Solar's strategic initiative to enhance its core solar energy operations with long-term research efforts aimed at carbon reduction [2][3]. - P2 Solar will maintain its focus on developing and deploying distributed solar energy systems while P2 CleanTech Labs will serve as a dedicated platform for research and development initiatives [3]. Group 2: Leadership Insights - Raj-Mohinder S. Gurm, CEO and Chairman of P2 Solar, emphasized the importance of investing in new technologies to address long-term environmental challenges through the establishment of P2 CleanTech Labs [3]. Group 3: Future Updates - Further updates regarding P2 CleanTech Labs and its activities will be provided as development progresses [4].

Core Insights - EssilorLuxottica and Meta are expanding their AI glasses portfolio with the introduction of new optical-first styles under the Ray-Ban Meta brand, specifically designed for prescription wearers [2][3] - The new collection includes Ray-Ban Meta Blayzer Optics (Gen 2) and Scriber Optics (Gen 2), featuring enhanced comfort, customization, and advanced AI capabilities [3][6] - The partnership aims to pioneer AI glasses for prescription wearers, enhancing user experience with features like live translation and nutrition tracking [6][7] Product Features - The Ray-Ban Meta collection offers a slimmer design with interchangeable nose pads, overextension hinges for an additional 10° of rotation, and adjustable temple tips [3] - Both new models support a wide range of lens designs, including advanced single-vision, progressive, and Transitions lenses, allowing seamless transition from day to night [3] - Oakley Meta products will also see new colorways and the introduction of Transitions lenses, which adapt to light conditions, enhancing visual clarity for athletes and consumers [4] Market Expansion - The AI glasses collection will expand to new regions including Japan, South Korea, Singapore, Chile, Peru, and Colombia later this year [5] - The Ray-Ban Meta collection will be available for pre-order in the U.S. starting March 31, with general availability from April 14 across various retail locations [9][10] Pricing - Suggested retail prices for the new Ray-Ban Meta Blayzer Optics (Gen 2) and Scriber Optics (Gen 2) are set at USD 499 and EUR 469 respectively [10]

Core Viewpoint - Angkor Resources Corp. has initiated a 20 line-kilometre Induced Polarization (IP) geophysical survey at the Gossan Hills target in Cambodia, aimed at detecting sulphide mineralization and advancing towards a drilling decision [1][2]. Survey Details - The IP survey utilizes a dipole-dipole configuration to measure chargeability, which helps distinguish sulphide minerals from barren rock [2]. - The survey will cover 20 line-kilometres with 2,500-metre lines, producing 2-D cross-sectional images of the subsurface to visualize sulphide-bearing zones [2]. Geological Context - Gossan Hills features calcareous metasediments that are highly reactive to mineralizing fluids, forming a skarn system indicative of potential economic mineralization [5][6]. - The geological interpretation suggests a systematic geochemical zonation from iron oxides to copper-rich zones, supporting the potential for a well-developed skarn system [6][8]. Independent Support - Recent research from ITC researchers indicates that the mineral presence at Gossan Hills suggests a potential association with skarn-type or sulfide-related mineralization, marking it as a promising exploration target [10]. Local Engagement and Education - The IP survey crew includes a team from the Institute of Technology of Cambodia (ITC), contributing to local capacity building in applied geophysics [11]. - The collaboration with ITC also extends to Angkor's energy subsidiary, EnerCam, enhancing hands-on training for students in seismic interpretation [12].

Company Overview - BayFirst Financial Corp. is a registered bank holding company based in St. Petersburg, Florida, which commenced operations on September 1, 2000 [3] - The primary source of income is derived from its wholly owned subsidiary, BayFirst National Bank, which began operations on February 12, 1999 [3] - As of December 31, 2025, BayFirst Financial Corp. had total assets of $1.30 billion [3] Upcoming Financial Results - The company will report its first quarter results after the market close on Thursday, April 30, 2026 [1] - Management will host a conference call on Friday, May 1, 2026, at 9:00 a.m. ET to discuss the results [1] - The call will be broadcast live via the internet, and interested investors can listen under the Investor Relations tab on the company's website [2] Participation Details - Investment professionals are invited to participate in the call by dialing (800) 549-8228 using Conference ID 37957 [2] - A replay of the call will be available for one year on the company's website [2]

Core Insights - The study indicates that SUBLOCADE, an extended-release buprenorphine injection, may significantly reduce staff time and associated costs in jails and prisons compared to other medications for opioid use disorder (MOUD) [1][2][3] Group 1: Cost Impact Model Findings - The model estimates that using monthly injectable buprenorphine requires fewer staff hours than other MOUD treatments, with reductions of 318 hours compared to methadone, 747 hours compared to oral buprenorphine, 192 hours compared to weekly extended-release buprenorphine, and 6 hours compared to extended-release naltrexone [7] - The estimated monthly cost savings from reduced staff time range from $23 to $22,148, with the largest savings resulting from the elimination of daily observed dosing and patient escorts [7] Group 2: Staffing Challenges in Correctional Facilities - Correctional facilities are facing ongoing staffing constraints as the demand for MOUD continues to grow, with nearly half of U.S. jails and prisons citing staffing as a primary barrier to providing MOUD [2][3] - The findings suggest that monthly injectable buprenorphine can alleviate the dosing burden and staff involvement, allowing facilities to operate more efficiently while expanding access to evidence-based care [2][3] Group 3: Study Background and Limitations - The study was funded by Indivior and conducted in collaboration with Veradigm and researchers from the University of Kentucky College of Medicine [4] - Limitations of the study include the exclusion of medication acquisition costs and some administration times based on assumptions due to a lack of available data [3]